Zions Bancorporation’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-251
Closed -$9.21K 1065
2022
Q4
$9.21K Buy
+251
New +$9.92K ﹤0.01% 738
2022
Q3
Sell
-66
Closed -$5K 1105
2022
Q2
$5K Sell
66
-24
-27% -$1.75K ﹤0.01% 874
2022
Q1
$7K Buy
+90
New +$7.61K ﹤0.01% 908

Other funds holding SYNH

Zions Bancorporation's SYNH Position: Q1 2023 in Review

Zions Bancorporation sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2023, closing a stake of 251 shares — an estimated $9.21K sold.

Zions Bancorporation first reported a position in SYNH in Q1 2022 and held it in 3 quarters. The position peaked at $9.21K in Q4 2022. 305 funds tracked by Wall St. Rank hold SYNH as of Q1 2023.

  • Zions Bancorporation reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Zions Bancorporation sold 251 Syneos Health, Inc. Class A Common Stock shares in Q1 2023, an estimated $9.21K.
  • Zions Bancorporation first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2022 and held it in 3 quarters.
  • Zions Bancorporation's Syneos Health, Inc. Class A Common Stock position peaked at $9.21K in Q4 2022.
  • 305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2023.

Based on Zions Bancorporation's 13F filing for Q1 2023, filed 10 May 2023.